
Seizing Opportunity: The Post-Pandemic Future of Life Sciences M&A 2022
Seizing Opportunity: The Post-Pandemic Future of Life Sciences M&A 2022
The third-annual Mintz and Mergermarket report on M&A in the life sciences examines the peak dealmaking activity of 2021 and the industry's robust M&A path. Our survey of 100 US-based executives explores the role of new technology and strong revenues, the growth of partnerships, and emerging post-merger cultural and personnel challenges.
Read the reportAwards and Recognition
More from Mintz
Our Offices
-
Boston
t / 617.542.6000 -
Los Angeles
t / 310.586.3200 -
New York
t / 212.935.3000 -
San Diego
t / 858.314.1500 -
San Francisco
t / 415.432.6000 -
Washington, DC
t / 202.434.7300 -
London
t / 44.20.3868.6112